Benoit Gravel

Benoit Gravel

Director/Board Member at MEDEXUS PHARMACEUTICALS INC.

Net worth: 238 262 $ as of 31/05/2026

Health Technology
Finance
Consumer Services

Profile

Benoit Gravel currently works at Medexus Pharmaceuticals, Inc., as Independent Director from 2017.
Mr. Gravel also formerly worked at The Public Sector Pension Investment Board, as Chairman, Tm Bioscience Corp., as Director, Lumira Capital Investment Management, Inc., as Director, Rhone-Poulenc Canada, Inc., as Director-Corporate Planning & Business Development from 1995 to 2000, Zentiva Group as, as Vice President-Global Portfolio Management from 2014 to 2016, Aventis Pasteur Ltd., as Vice President-Commercial Affairs, Sanofi Canada, Inc., as VP-Diabetes & Specialized Care Unit from 2012 to 2014, and Gerson Lehman Group (Asia) Ltd., as Member-Healthcare Council from 2016 to 2022.
Mr. Gravel received his undergraduate degree and graduate degree from the University of Montréal.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/12/2025 85,368 ( 0.26% ) 238 262 $ 31/05/2026

Benoit Gravel active positions

CompaniesPositionStart
MEDEXUS PHARMACEUTICALS INC. Director/Board Member 22/09/2017

Former positions of Benoit Gravel

CompaniesPositionEnd
Gerson Lehman Group (Asia) Ltd.
Corporate Officer/Principal 01/01/2022
Corporate Officer/Principal 01/02/2016
Corporate Officer/Principal 01/01/2014
Corporate Officer/Principal 01/01/2000
Aventis Pasteur Ltd.
Corporate Officer/Principal -
See the detail of Benoit Gravel's experience

Training of Benoit Gravel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

9

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Finance

Health Technology

Finance

Consumer Services

Aventis Pasteur Ltd.

Finance

Health Technology

Health Technology

Gerson Lehman Group (Asia) Ltd.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!